World's leading clinical conference on bone, joint and muscle health
Programme
Friday May 5th - CEST Time zone
08:00 - 09:00
Non-Sponsored Symposia
08:00
Room 123
Capture the Fracture® - Advocating for effective and sustainable strategies for secondary fracture prevention
Chairperson :
Nicholas Harvey
- The role of orthopaedic surgeon in the FLS
- 20 years of experiences with an FLS
- Running an FLS is cost-effective
- Running an FLS is not only reducing fractures, but also reduces mortality
- Panel discussion
08:00
Room 129
Capture the Fracture mentorship – global delivery and what we have learnt
Chairperson :
Kassim Javaid
- Overview and progress
- The Role of the IOF Coordinator
- Country specific outcomes / resources/ events : LATAM
- Country specific outcomes / resources/ events : Europe
- Country specific outcomes / resources/ events : APAC
- Panel Discussion – How to improve mentorship for the future
08:00
Room 130
Non-sponsored symposium of the GRIIP - “PRP in the management of musculoskeletal diseases”
Chairperson :
Jean-François Kaux
- Efficacy of PRP in tendinopathies
- Standardisation of PRP in the management of knee and hip osteoarthritis
- Future perspectives for the use of PRP in the management of musculoskeletal disorders
08:00
Room 122
Osteoporosis and life: from childhood to aging
Chairperson :
Juan Jose Scali
- Introduction to Symposium
- Osteoporosis in childhood and teenagers
- Osteoporosis in reproductive life
- Osteoporosis in aged: What we know and what we need to know?
- Questions and comments from the audience
08:00
Room 120
Challenging decisions in Osteoporosis Management
Chairpersons :
Yasser El Miedany
& Naglaa Gadallah
- Osteoporosis case ascertainment strategies: North Africa Experience
- DXA scan: Beyond BMD measurement
- Management of osteoporosis before the age of 50
08:00
Room 118
Diabetes, Obesity bone and fractures. Myths and Pearls.
Chairpersons :
Peter Ebeling
, Sonia Cerdas Perez
& Jose Luis Neyro Bilbao
- Diabetes and bone metabolism
- Obesity, bone metabolism, osteoporosis and fractures
08:00
Room 133-134
Accelerating musculoskeletal healthcare into the 21st century: Insights to real-world implementation of digital health technologies for osteoporosis, sarcopenia, falls and fractures.
Chairperson :
Mylene Aubertin-Leheudre
- Going digital – The role of digital health technologies for geriatric assessments and the remote delivery and monitoring of exercise and lifestyle interventions for older adults
- Digital voice assistants: A novel technological approach to supporting older adults to self-manage musculoskeletal conditions
- Social disadvantage and musculoskeletal health: Ensuring that the ‘digital divide’ does not impact on the equitable delivery of care
08:00
Room 121
Physical activity and exercise in mild cognitive impairment and dementia: guidelines from European societies
Chairperson :
Olivier Bruyère
- Physical activity and exercise for the prevention of dementia
- Importance of physical activity and exercise in mild cognitive impairment
- Physical activity and exercise in mild cognitive impairment and dementia: guidelines from European societies
08:00
Room 119
The influence of exercise on the chronic low-grade inflammatory profile
Chairperson :
Ivan Bautmans
- Strength training alters lps-induced immune responses in peripheral mononuclear blood cells of older persons
- Three months of resistance training alters the expression of inflammation related genes in PBMCS with a LPS challenge
- Is physical activity associated with pre-frailty, T-cell phenotypes and inflammation in the oldest old?
- Effects of daily immunonutrient intake on inflammation and sarcopenia: Role of physical activty
- Intra-articular biomarkers and characteristics of pain sensitization: How are they related to each other in knee osteoarthritis patients?
- Can exercise therapy influence inflammatory markers and BDNF in patients with knee osteoarthritis? A systematic review with meta-analysis
- Discussion
08:00 - 09:00
Auditorium B
Sponsored Breakfast Satellite Symposium
09:00 - 10:30
Auditorium A
Scientific Session I
Chairpersons :
Bess Dawson-Hughes
& Philippe Halbout
09:00
Auditorium A
Plenary Lecture 1
To treat or not to treat: Continuous or intermittent therapies in osteoporosis
09:30
Auditorium A
Oral communication selected from abstracts
OC1: ONE YEAR OF ROMOSOZUMAB FOLLOWED BY ONE YEAR OF DENOSUMAB VERSUS TWO YEARS OF DENOSUMAB: BMD AND FRACTURE RESULTS FROM THE FRAME AND FRAME EXTENSION STUDIES
Presenting author:
Authors:
09:40
Auditorium A
Oral communication selected from abstracts
OC2: EFFECTIVENESS OF ASFOTASE ALFA FOR TREATMENT OF ADULTS WITH HYPOPHOSPHATASIA: RESULTS FROM A GLOBAL REGISTRY
Presenting author:
Authors:
09:50
Auditorium A
Oral communication selected from abstracts
OC3: PRE-TREATMENT LEVEL OF BONE TURNOVER DOES NOT INFLUENCE THE RESPONSE TO ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS. A LARGE HISTOMORPHOMETRIC STUDY
Presenting author:
Authors:
10:00
Auditorium A
Oral communication selected from abstracts
OC4: EFFICACY AND SAFETY OF PROPOSED DENOSUMAB BIOSIMILAR AND REFERENCE DENOSUMAB IN POSTMENOPAUSAL OSTEOPOROSIS AT 52 WEEKS: THE ROSALIA STUDY
Presenting author:
Authors:
10:10
Auditorium A
Oral communication selected from abstracts
OC5: COST-EFFECTIVENESS OF ABALOPARATIDE FOLLOWED BY ALENDRONATE IN US WOMEN AND MEN AT HIGH RISK OF OSTEOPOROTIC FRACTURES
Presenting author:
Authors:
10:20
Auditorium A
Oral communication selected from abstracts
OC6: COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ALENDRONATE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE U.S. MEDICARE PROGRAM
Presenting author:
Authors:
10:30 - 12:10
Auditorium A
Scientific Session II
Chairpersons :
John A. Kanis
& Charlotte Beaudart
10:30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
10:40
Auditorium A
Plenary Lecture 2
Should the punishment fit the crime? Osteoporosis treatment in relation to fracture risk
11:20
Auditorium A
Oral communication selected from abstracts
OC7: SINGLE WOMEN SHOW HIGHER FRACTURE RATES AND DIFFERENT ANTHROPOMETRIC, SOCIOECONOMIC AND LIFESTYLE PROFILES RELATIVE TO THEIR COUNTERPARTS IN RELATIONSHIPS: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author:
Authors:
11:30
Auditorium A
Oral communication selected from abstracts
OC8: ADJUSTING CONVENTIONAL FRAX ESTIMATES OF FRACTURE PROBABILITY ACCORDING TO THE NUMBER OF PRIOR FRACTURES
Presenting author:
Authors:
11:40
Auditorium A
Oral communication selected from abstracts
OC9: FRACTURE PATTERNS IN T1D AND THEIR ASSOCIATED RISK FACTORS – A RETROSPECTIVE COHORT STUDY
Presenting author:
Authors:
11:50
Auditorium A
Oral communication selected from abstracts
OC10: TYPE 1 AND 2 DIABETES MELLITUS AND INCIDENT FRACTURE RISK IN UK BIOBANK: IMPACT OF DISEASE TYPE, DURATION AND MICROVASCULAR COMPLICATIONS
Presenting author:
Authors:
12:00
Auditorium A
Sponsored session
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium
12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium
13:45 - 14:00
Podium
IOF Young Investigator Nutrition Research Grants Ceremony
14:00 - 15:00
Meet-The-Expert Session
14:00
Room 121
Disorders of phosphate homeostasis
14:00
Room 120
Sport : how much is too much?
14:00
Room 119
Post-fracture management
14:00
Room 133-134
New guidelines on the management of primary hyperparathyroidsm
14:00 - 15:00
Poster Area
Poster Viewing Session I
14:00 - 15:10
Podium
Oral presentation of selected posters
Chairperson :
Elaine Dennison
14:00
Podium
P506
HAND GRIP STRENGTH TEST AND SHORT PHYSICAL PERFORMANCE BATTERY VERSUS FRAX®: WHICH CORRELATION IN THE FRACTURE RISK? A MACHINE LEARNING STUDY
Presenting author:
Authors:
14:07
Podium
P168
DIGITAL VOICE ASSISTANTS FOR DELIVERING EXERCISE, NUTRITION AND MEDICATION INFORMATION TO POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: A 24-WEEK PILOT RANDOMISED CONTROLLED TRIAL
Presenting author:
Authors:
14:14
Podium
P220
TREATMENT GAP AFTER OSTEOPOROTIC FRAGILITY FRACTURES - A REGIONAL ANALYSIS IN GERMANY
Presenting author:
Authors:
14:21
Podium
P258
ZOLEDRONIC ACID AFTER SPINAL CORD INJURY MITIGATES LOSSES IN PROXIMAL FEMORAL STRENGTH: A POST-HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
Presenting author:
Authors:
14:28
Podium
P264
A PHASE 1, OPEN-LABEL, DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALXN1850 IN ADULTS WITH HYPOPHOSPHATASIA
Presenting author:
Authors:
14:35
Podium
P290
EXECUTIVE FUNCTION AND INTELLIGENCE: ASSOCIATIONS WITH BONE SIZE AND MINERAL DENSITY IN CHILDHOOD
Presenting author:
Authors:
14:42
Podium
P403
A PROSPECTIVE STUDY TO EVALUATE PATIENT-REPORTED QUALITY OF LIFE PRIOR TO AND AFTER ASFOTASE ALFA TREATMENT IN ADULTS WITH PEDIATRIC-ONSET HYPOPHOSPHATASIA
Presenting author:
Authors:
14:49
Podium
P416
MOBILITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH PAEDIATRIC-ONSET HYPOPHOSPHATASIA TREATED WITH ASFOTASE ALFA: INTERIM ANALYSIS FROM THE UK MANAGED ACCESS AGREEMENT
Presenting author:
Authors:
14:56
Podium
P511
ISCHEMIC STROKE IS ASSOCIATED WITH REDUCED SCLEROSTIN EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES
Presenting author:
Authors:
15:03
Podium
P609
EFFECTS OF PARATHYROIDECTOMY ON RISK OF FRACTURE BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY
Presenting author:
Authors:
14:00 - 15:00
Room 131-132
Special Educational Lecture
Assessment of quality of life: state of the art
14:00 - 15:00
Room 118
ESCEO-OARSI Symposium - Why or why not osteoporosis medications work for osteoarthritis?
Chairpersons :
Jean-Yves Reginster
& Gun-il Im
- Introduction
- Impact of anti-osteoporosis medications on pre-clinical models of osteoarthritis
- Outcomes of clinical trials having assessed anti-osteoporosis drugs in osteoarthritis
- Why did the studies assessing anti-osteoporosis drugs in osteoarthritis fail?
- Subchondral bone as a target for anti-osteoarthritis medications: how can we identify the most appropriate patients to be included in clinical trials?
14:00 - 15:00
Room 130
ESCEO SYMPOSIUM - Recommendations for the selection of biochemical markers of musculoskeletal health and aging to be assessed in clinical trials of drugs aiming at the management of sarcopenia
Chairpersons :
Etienne Cavalier
& René Rizzoli
- Introduction
- Why do we need biomarkers in sarcopenia research?
- Which biomarkers for which studies
14:00 - 15:00
Room 123
Sponsored Meet-The-Expert Session
14:00 - 15:00
Room 122
Update on the use of TBS in the management of osteoporosis: Working Group organized by ESCEO and IOF under the auspices of the WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
Chairpersons :
Olivier Lamy
& Nicholas Harvey
- New insight on the use of TBS in clinical practice
- Role of TBS in the management of osteoporosis
- Discussion - Doctor Sansin Tuzun (Leader)
15:00 - 17:00
Auditorium A
Scientific Session III
Chairpersons :
Nicholas Harvey
& Ngozi Njeze
15:00
Auditorium A
Plenary Lecture 3
Obesity, weight loss and bone health: what risk and which fractures?
15:30
Auditorium A
Oral communication selected from abstracts
OC11: HEALTH-RELATED QUALITY OF LIFE IN SARCOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author:
Authors:
15:40
Auditorium A
Oral communication selected from abstracts
OC12: DYNAPENIC ABDOMINAL OBESITY AND SUSCEPTIBILITY TO FALL: A PROSPECTIVE ANALYSIS OF THE OSTEOARTHRITIS INITIATIVE
Presenting author:
Authors:
15:50
Auditorium A
Oral communication selected from abstracts
OC13: SARCOPENIA DEFINITIONS AND THEIR ASSOCIATION WITH FRACTURE RISK IN OLDER SWEDISH WOMEN. THE SAHLGRENSKA UNIVERSITY HOSPITAL PROSPECTIVE EVALUATION OF RISK OF BONE FRACTURES (SUPERB) STUDY
Presenting author:
Authors:
16:00
Auditorium A
Oral communication selected from abstracts
OC14: PREDICTORS OF 8-YEAR SURVIVAL IN NURSING HOMES: RESULTS FROM THE SENIOR COHORT.
Presenting author:
Authors:
16:10
Auditorium A
Oral communication selected from abstracts
OC15: THE ASSOCIATIONS BETWEEN OSTEOSARCOPENIA AND FALLS, FRACTURES, AND FRAILTY IN OLDER ADULTS: RESULTS FROM THE CANADIAN LONGITUDINAL STUDY ON AGING (CLSA)
Presenting author:
Authors:
16:20
Auditorium A
Oral communication selected from abstracts
OC16: MUSCLE SIZE AND DENSITY ARE INDEPENDENTLY ASSOCIATED WITH DEATH AFTER HIP FRACTURE: A PROSPECTIVE COHORT STUDY
Presenting author:
Authors:
16:30
Auditorium A
Plenary Lecture 4
Bone: an affair of the heart or of the brain?
15:00 - 16:45
Room 131-132
Committee of National Societies Special Plenary Session
Progress in osteoporosis and fragility fracture management around the world
Chairpersons :
Jean-Yves Reginster
& Famida Jiwa
15:03
Room 131-132
OCs1: APPLICATION OF DEEP LEARNING ALGORITHM TO DETECT AND VISUALIZE VERTEBRAL FRACTURES ON PLAIN FRONTAL RADIOGRAPHS
Presenting author:
Authors:
15:11
Room 131-132
OCs2: ASSESSMENT OF MACHINE LEARNING MODELS FOR FRACTURE RISK PREDICTION
Presenting author:
Authors:
15:19
Room 131-132
OCs3: SCREENING FOR SARCOPENIA IN OLDER COMMUNITY-DWELLING ADULTS: FINDINGS FROM SOUTHAMPTON LONGITUDINAL STUDY OF AGEING (SALSA)
Presenting author:
Authors:
15:27
Room 131-132
OCs4: PATIENTS’ PREFERENCES FOR COMMUNICATING FRACTURE RISK: THE RISK COMMUNICATION IN OSTEOPOROSIS (RICO) STUDY
Presenting author:
Authors:
15:35
Room 131-132
OCs5: SHORT-TERM (2-YEARS) FRACTURE RISK PREDICTION: A MACHINE LEARNING APPROACH
Presenting author:
Authors:
15:45
Room 131-132
Presentation of the IOF Committee of National Societies Medal
15:50
Room 131-132
Presentation of the ESCEO-Aging Clinical and Experimental Research, Stefania Maggi Prize
15:55
Room 131-132
OCs6: APPENDICULAR LEAN MASS AND FAT PERCENTAGES CUTOFF VALUES TO DEFINE SARCOPENIC OBESITY IN UKRAINE COMMUNITY-DWELLING OLDER ADULTS
Presenting author:
Authors:
16:03
Room 131-132
OCs7: THE CONCEPT OF ‘TIME TO FIRST FRACTURE’ IN THE FRISBEE COHORT: ANALYSIS OF RISK FACTORS AND ASSOCIATION WITH ‘IMMINENT FRACTURES’
Presenting author:
Authors:
16:11
Room 131-132
OCs8: APPLICATION OF TOMOSYNTHESIS FOR VERTEBRAL COMPRESSION FRACTURE DIAGNOSIS AND BONE HEALING ASSESSMENT IN FRACTURE LIAISON SERVICES
Presenting author:
Authors:
16:19
Room 131-132
OCs9: THE ASSOCIATION OF REGIONAL BODY MUSCLE MASS AND FATTY LIVER INDEX IN OLDER PEOPLE: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author:
Authors:
16:27
Room 131-132
OCs10: ASSOCIATIONS BETWEEN HEALTH LITERACY AND BONE, MUSCLE, AND PHYSICAL FUNCTION OUTCOMES IN COMMUNITY-DWELLING OLDER ADULTS
Presenting author:
Authors:
16:35
Room 131-132
OCs11: A SYSTEMATIC REVIEW AND CRITICAL APPRAISAL OF QUALITY INDICATORS TO ASSESS OPTIMAL CARE FOR FRAGILITY HIP FRACTURE
Presenting author:
Authors:
17:00 - 18:30
Auditorium A
Sponsored Satellite Symposium